Congress mandates insurance coverage for ovarian cancer genetic testing and preventive surgery

What it does

This bill expands federal programs to improve ovarian cancer prevention, detection, and treatment by funding public awareness campaigns, demonstration projects in underserved areas, and requiring health insurance plans to cover genetic counseling, genetic testing, and risk-reducing surgeries for people at hereditary risk. It directs the Department of Health and Human Services to coordinate efforts across agencies and report on progress in closing care gaps, particularly in rural and low-income communities.

Why we flagged it

The bill's operative mechanism is straightforward: it funds awareness and demonstration projects, mandates insurance coverage for genetic testing and preventive interventions, and directs federal agencies to coordinate and report on implementation. No hidden mechanisms, no narrow carve-outs, no self-dealing provisions.

What the text implies

• Insurance coverage mandate may increase demand for genetic counseling and testing services, potentially straining capacity in underserved areas unless demonstration projects successfully build provider infrastructure.
• Requirement that 'least restrictive' guideline applies when professional organizations conflict may expand coverage scope beyond some insurers' initial interpretation, increasing plan costs.
• Tumor genomic profiling and somatic mutation testing coverage (subsection (a)(1)(B)(iv)) extends beyond germline hereditary risk assessment to post-diagnosis treatment selection, broadening the bill's scope beyond prevention.
• Privacy protections language (subsection (g)) references 'all applicable Federal and State privacy laws' but does not establish new genetic privacy safeguards specific to ovarian cancer testing, leaving implementation to existing frameworks.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary people at hereditary ovarian cancer risk gain access to genetic counseling, testing, and preventive surgeries that may reduce cancer incidence and mortality. Rural and medically underserved populations, who face documented disparities in access to specialty care, are explicitly targeted for outreach and demonstration projects. Insurance coverage mandates remove cost barriers to evidence-based preventive interventions.

Who stands to gain

• genetic testing laboratories and companies offering multi-gene panel testing
• genetic counseling providers and telehealth platforms offering remote counseling
• academic medical centers and specialty oncology practices receiving demonstration project grants
• rural hospitals and community health centers receiving rural outreach funding

Named in the bill

Department of Health and Human Services, Centers for Disease Control and Prevention, Health Resources and Services Administration, National Cancer Institute, National Comprehensive Cancer Network, American Society of Clinical Oncology, Society of Gynecologic Oncology, State, local, and Tribal public health departments, Community health centers, Rural hospitals, Academic medical centers, Nonprofit organizations

Where it stands

1 cosponsor: 1 Republicans.

• Sep 24, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Sep 24, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.